Yuki Hoshi

P1.232. Treatment Outcomes of Conversion Surgery for Advanced Esophageal Cancer Following ICI-Combined Chemotherapy

Esophageal Cancer: Surgical Treatment of Esophageal Cancer – long term outcomes Immune checkpoint inhibitor (ICI)-based combination chemotherapy for advanced esophageal cancer demonstrates high response rates, enabling conversion surgery in some cases. However, reports on the safety and prognosis of cases...

OA03-RF01.08. Clinical Significance of Circulating Tumor DNA Dynamics in Patients With Esophageal Squamous Cell Carcinoma

Esophageal Cancer: New Diagnostic Modalities (Including PET, PET-CT, New Tracers) In the perioperative management of esophageal squamous cell carcinoma (ESCC), the accuracy of conventional modalities such as computed tomography and esophagogastroduodenoscopy remains unsatisfactory for predicting recurrence...

Clinical significance of combining circulating tumor DNA and endoscopic response evaluation for esophageal squamous cell carcinoma.